U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 305

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr5:88100457
GRCh38:
Chr5:88804640
MEF2CY72*Intellectual disability, autosomal dominant 20Likely pathogenic
(Nov 24, 2023)
no assertion criteria provided
2.
GRCh37:
Chr5:88024338
GRCh38:
Chr5:88728521
MEF2CM208V, M310V, M358V, M350V, M368V, M348V, M232V, M302VIntellectual disability, autosomal dominant 20Uncertain significancecriteria provided, single submitter
3.
GRCh38:
Chr5:88189536-93784597
ADGRV1, ARB2A, ARRDC3, ARRDC3-AS1, CETN3, CRE1, LINC01339, LINC02060, LOC102724637, LOC105379082, LOC110120605, LOC110120640, LOC110120688, LOC110120699, LOC110120744, LOC110120771, LOC110120808, LOC110120815, LOC110120966, LOC110120971, LOC110120974, LOC110120977, LOC110120982, LOC110120991, LOC110121009, LOC110121012, LOC110121013, LOC110121035, LOC110121147, LOC121079950, LOC123497931, LOC123497932, LOC123497933, LOC123497934, LOC123497935, LOC123497936, LOC123497937, LOC123497938, LOC123497939, LOC126807447, LOC126807448, LOC126807449, LOC126807450, LOC126807451, LOC126807452, LOC128772265, LOC128772266, LOC128772267, LOC128772268, LOC128772269, LOC128772270, LOC128772271, LOC128772272, LOC128772273, LOC129389317, LOC129389318, LOC129389319, LOC129389320, LOC129389321, LOC129994175, LOC129994176, LOC129994177, LOC129994178, LOC129994179, LOC129994180, LOC129994181, LOC129994182, LOC129994183, LOC129994184, LOC129994185, LOC129994186, LOC129994187, LOC129994188, LOC129994189, LOC129994190, LOC129994191, LOC129994192, LOC129994193, LOC129994194, LOC129994195, LOC129994196, LOC129994197, LOC129994198, LOC129994199, LOC129994200, LOC129994201, LOC129994202, LOC129994203, LOC129994204, LOC129994205, LOC129994206, LOC129994207, LOC129994208, LOC129994209, LOC129994210, LOC129994211, LOC129994212, LOC129994213, LOC129994214, LOC129994215, LOC129994216, LOC731157, LUCAT1, LYSMD3, MBLAC2, MEF2C, MEF2C-AS1, MEF2C-AS2, MIR2277, MIR3660, MIR9-2, MIR9-2HG, NR2F1, NR2F1-AS1, POLR3G, POU5F2, TMEM161B, TMEM161B-DT
Intellectual disability, autosomal dominant 20Pathogenic
(Aug 24, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr5:88057001
GRCh38:
Chr5:88761184
MEF2CIntellectual disability, autosomal dominant 20Pathogenic
(Feb 17, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr5:88100432
GRCh38:
Chr5:88804615
MEF2CN81DIntellectual disability, autosomal dominant 20Pathogenic
(Apr 13, 2023)
criteria provided, single submitter
6.
GRCh37:
Chr5:88100463
GRCh38:
Chr5:88804646
MEF2CE71fsIntellectual disability, autosomal dominant 20Pathogenic
(May 31, 2023)
criteria provided, single submitter
7.
GRCh37:
Chr5:88100580-88100582
GRCh38:
Chr5:88804763-88804765
MEF2CK31delIntellectual disability, autosomal dominant 20Pathogenic
(May 31, 2023)
criteria provided, single submitter
8.
GRCh37:
Chr5:88100584
GRCh38:
Chr5:88804767
MEF2CK30TIntellectual disability, autosomal dominant 20Likely pathogenic
(May 8, 2023)
criteria provided, single submitter
9.
GRCh37:
Chr5:88119584
GRCh38:
Chr5:88823767
MEF2CI8LIntellectual disability, autosomal dominant 20Likely pathogenic
(Dec 16, 2019)
criteria provided, single submitter
10.
GRCh37:
Chr5:88100567
GRCh38:
Chr5:88804750
MEF2CS36RIntellectual disability, autosomal dominant 20Likely pathogenic
(Oct 15, 2020)
criteria provided, single submitter
11.
GRCh37:
Chr5:88047783
GRCh38:
Chr5:88751966
MEF2CIntellectual disability, autosomal dominant 20Uncertain significance
(Nov 6, 2020)
criteria provided, single submitter
12.
GRCh37:
Chr5:88027632
GRCh38:
Chr5:88731815
MEF2CP100A, P116A, P194A, P240A, P242A, P260AIntellectual disability, autosomal dominant 20Uncertain significance
(Mar 21, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr5:88119563
GRCh38:
Chr5:88823746
MEF2CR15GIntellectual disability, autosomal dominant 20Uncertain significance
(Dec 6, 2019)
criteria provided, single submitter
14.
GRCh37:
Chr5:88018636
GRCh38:
Chr5:88722819
MEF2C, MEF2C-AS2H322L, H360L, H362L, H370L, T221S, T245S, T277S, T323S, T347S, T355S, T361S, T363S, T371S, T381S, T393S, T395S, T403S, T413SIntellectual disability, autosomal dominant 20Uncertain significance
(Jun 18, 2020)
criteria provided, single submitter
15.
GRCh37:
Chr5:88056982-88119605
MEF2CIntellectual disability, autosomal dominant 20Pathogenic
(Mar 20, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr5:88100395-88119605
MEF2CIntellectual disability, autosomal dominant 20Pathogenic
(Sep 25, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr5:88100395-88100638
MEF2CIntellectual disability, autosomal dominant 20Pathogenic
(May 9, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr5:88025107
GRCh38:
Chr5:88729290
MEF2CV172I, V308I, V148I, V288I, V242I, V298I, V250I, V290IIntellectual disability, autosomal dominant 20Uncertain significance
(Jul 9, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr5:88025184
GRCh38:
Chr5:88729367
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Apr 11, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr5:88119566
GRCh38:
Chr5:88823749
MEF2CE14KIntellectual disability, autosomal dominant 20Uncertain significance
(Nov 28, 2021)
criteria provided, single submitter
21.
GRCh37:
Chr5:88044949
GRCh38:
Chr5:88749132
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Aug 22, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr5:88026015
GRCh38:
Chr5:88730198
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Feb 25, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr5:88100594
GRCh38:
Chr5:88804777
MEF2CG27RIntellectual disability, autosomal dominant 20Likely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr5:88027627
GRCh38:
Chr5:88731810
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Sep 8, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr5:88027729
GRCh38:
Chr5:88731912
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Dec 24, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr5:88024462-88024464
GRCh38:
Chr5:88728645-88728647
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Dec 16, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr5:88119540
GRCh38:
Chr5:88823723
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(May 24, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr5:88027587
GRCh38:
Chr5:88731770
MEF2CV255L, V115L, V209L, V275L, V131L, V257LIntellectual disability, autosomal dominant 20Uncertain significance
(Oct 5, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr5:88018705
GRCh38:
Chr5:88722888
MEF2CL254I, L332I, L370I, L372I, L390I, L324I, L380IIntellectual disability, autosomal dominant 20Uncertain significance
(May 12, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr5:88026039
GRCh38:
Chr5:88730222
MEF2CD149H, D227H, D275HIntellectual disability, autosomal dominant 20Uncertain significance
(Apr 23, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr5:88100574
GRCh38:
Chr5:88804757
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Apr 25, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr5:88057161
GRCh38:
Chr5:88761344
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Apr 1, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr5:88024373
GRCh38:
Chr5:88728556
MEF2CS298L, S338L, S220L, S336L, S346L, S356L, S196L, S290LIntellectual disability, autosomal dominant 20Uncertain significance
(Sep 7, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr5:88100545
GRCh38:
Chr5:88804728
MEF2CI43SIntellectual disability, autosomal dominant 20Uncertain significance
(Oct 13, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr5:88100542
GRCh38:
Chr5:88804725
MEF2CA44EIntellectual disability, autosomal dominant 20Uncertain significance
(Oct 13, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr5:88027701
GRCh38:
Chr5:88731884
MEF2CP171T, P93T, P217T, P219T, P237T, P77TIntellectual disability, autosomal dominant 20Uncertain significance
(Feb 28, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr5:88047658
GRCh38:
Chr5:88751841
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Apr 4, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr5:88047752
GRCh38:
Chr5:88751935
MEF2CP169S, P189S, P29S, P45S, P123S, P171SIntellectual disability, autosomal dominant 20Uncertain significance
(Feb 20, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr5:88056983
GRCh38:
Chr5:88761166
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Feb 10, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr5:88057162
GRCh38:
Chr5:88761345
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Feb 21, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr5:88025118
GRCh38:
Chr5:88729301
MEF2CP246fs, P144fs, P168fs, P304fs, P294fs, P238fs, P284fs, P286fsIntellectual disability, autosomal dominant 20Pathogenic
(Feb 2, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr5:88025059
GRCh38:
Chr5:88729242
MEF2CA314S, A324S, A258S, A304S, A188S, A266S, A164S, A306SIntellectual disability, autosomal dominant 20Uncertain significance
(Jul 12, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr5:88119539
GRCh38:
Chr5:88823722
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Mar 12, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr5:88027725
GRCh38:
Chr5:88731908
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Oct 14, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr5:88100412
GRCh38:
Chr5:88804595
MEF2CIntellectual disability, autosomal dominant 20Uncertain significance
(Dec 15, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr5:88119546
GRCh38:
Chr5:88823729
MEF2CIntellectual disability, autosomal dominant 20Uncertain significance
(Dec 13, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr5:88024292
GRCh38:
Chr5:88728475
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Oct 17, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr5:88027732
GRCh38:
Chr5:88731915
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Sep 10, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr5:88027727
GRCh38:
Chr5:88731910
MEF2CIntellectual disability, autosomal dominant 20Benign
(Sep 12, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr5:88018607
GRCh38:
Chr5:88722790
MEF2C, MEF2C-AS2A372T, A332T, A370T, A380TIntellectual disability, autosomal dominant 20Likely benign
(Sep 6, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr5:88057101
GRCh38:
Chr5:88761284
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Sep 6, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr5:88018477
GRCh38:
Chr5:88722660
MEF2C, MEF2C-AS2E376*, E400*, E434*, E414*, E446*, E274*, E330*, E456*, E298*, E408*, E416*, E424*, E448*, E466*Intellectual disability, autosomal dominant 20Uncertain significance
(Sep 26, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr5:88024422
GRCh38:
Chr5:88728605
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Nov 30, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr5:88024354
GRCh38:
Chr5:88728537
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Jul 24, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr5:88018542
GRCh38:
Chr5:88722725
MEF2C, MEF2C-AS2S252N, S412N, S424N, S378N, S394N, S402N, S426N, S434N, S308N, S354N, S276N, S386N, S392N, S444NIntellectual disability, autosomal dominant 20Uncertain significance
(Jul 11, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr5:88057098
GRCh38:
Chr5:88761281
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Jul 5, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr5:88024410-88024411
GRCh38:
Chr5:88728593-88728594
MEF2CS344fs, S184fs, S208fs, S278fs, S324fs, S334fs, S286fs, S326fsIntellectual disability, autosomal dominant 20Pathogenic
(Jun 15, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr5:88047824
GRCh38:
Chr5:88752007
MEF2CI147V, I21V, I99V, I5V, I145V, I165VIntellectual disability, autosomal dominant 20Benign
(Oct 19, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr5:88047722
GRCh38:
Chr5:88751905
MEF2CS179G, S199G, S39G, S133G, S181G, S55GIntellectual disability, autosomal dominant 20Uncertain significance
(Jun 15, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr5:88047795
GRCh38:
Chr5:88751978
MEF2CY155fs, Y15fs, Y109fs, Y175fs, Y157fs, Y31fsIntellectual disability, autosomal dominant 20Pathogenic
(Sep 12, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr5:88018541
GRCh38:
Chr5:88722724
MEF2C, MEF2C-AS2Intellectual disability, autosomal dominant 20Likely benign
(May 30, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr5:88100582
GRCh38:
Chr5:88804765
MEF2CK31EIntellectual disability, autosomal dominant 20Uncertain significance
(May 21, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr5:88044886
GRCh38:
Chr5:88749069
MEF2CIntellectual disability, autosomal dominant 20Likely pathogenic
(Sep 7, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr5:88119555
GRCh38:
Chr5:88823738
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Oct 12, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr5:88047874
GRCh38:
Chr5:88752057
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(May 19, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr5:88027717
GRCh38:
Chr5:88731900
MEF2CIntellectual disability, autosomal dominant 20Pathogenic
(May 9, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr5:88024405
GRCh38:
Chr5:88728588
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Feb 18, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr5:88025144
GRCh38:
Chr5:88729327
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Jul 6, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr5:88027606
GRCh38:
Chr5:88731789
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Apr 29, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr5:88044929
GRCh38:
Chr5:88749112
MEF2CL199V, L151V, L197V, L73V, L217V, L57VIntellectual disability, autosomal dominant 20Uncertain significance
(Feb 21, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr5:88018502
GRCh38:
Chr5:88722685
MEF2C, MEF2C-AS2Intellectual disability, autosomal dominant 20Likely benign
(Mar 18, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr5:88018704
GRCh38:
Chr5:88722887
MEF2CL332H, L372H, L390H, L254H, L324H, L370H, L380HIntellectual disability, autosomal dominant 20Uncertain significance
(Dec 18, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr5:88018490
GRCh38:
Chr5:88722673
MEF2C, MEF2C-AS2Intellectual disability, autosomal dominant 20Likely benign
(Aug 27, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr5:88044938
GRCh38:
Chr5:88749121
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Sep 1, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr5:88057059
GRCh38:
Chr5:88761242
MEF2CD115EIntellectual disability, autosomal dominant 20Uncertain significance
(Jul 1, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr5:88100632
GRCh38:
Chr5:88804815
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Mar 11, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr5:88100415
GRCh38:
Chr5:88804598
MEF2CIntellectual disability, autosomal dominant 20Likely pathogenic
(Oct 19, 2020)
criteria provided, single submitter
78.
GRCh37:
Chr5:88025059-88025060
GRCh38:
Chr5:88729242-88729243
MEF2CA164fs, A188fs, A258fs, A266fs, A304fs, A306fs, A314fs, A324fsIntellectual disability, autosomal dominant 20Pathogenic
(Jun 11, 2020)
criteria provided, single submitter
79.
GRCh37:
Chr5:88025091
GRCh38:
Chr5:88729274
MEF2CL153fs, L177fs, L247fs, L255fs, L293fs, L295fs, L303fs, L313fsIntellectual disability, autosomal dominant 20Pathogenic
(Feb 2, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr5:88027610
GRCh38:
Chr5:88731793
MEF2CN107S, N123S, N201S, N247S, N249S, N267SIntellectual disability, autosomal dominant 20Uncertain significance
(Sep 28, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr5:88119553
GRCh38:
Chr5:88823736
MEF2CQ18RIntellectual disability, autosomal dominant 20Uncertain significance
(Sep 4, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr5:88025080
GRCh38:
Chr5:88729263
MEF2CG157R, G181R, G251R, G259R, G297R, G299R, G307R, G317RIntellectual disability, autosomal dominant 20Uncertain significance
(Jul 25, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr5:88057084
GRCh38:
Chr5:88761267
MEF2CV107AIntellectual disability, autosomal dominant 20Uncertain significance
(Jul 22, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr5:88625195-90796047
ADGRV1, ARRDC3, CETN3, LUCAT1, LYSMD3, MBLAC2, MEF2C, POLR3GIntellectual disability, autosomal dominant 20Pathogeniccriteria provided, single submitter
85.
GRCh37:
Chr5:88025166
GRCh38:
Chr5:88729349
MEF2CIntellectual disability, autosomal dominant 20Likely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr5:88065061-88406446
MEF2CIntellectual disability, autosomal dominant 20Pathogenicno assertion criteria provided
87.
GRCh37:
Chr5:88119562
GRCh38:
Chr5:88823745
MEF2CR15PIntellectual disability, autosomal dominant 20Pathogenic
(May 4, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr5:88100569
GRCh38:
Chr5:88804752
MEF2CL35PIntellectual disability, autosomal dominant 20Conflicting interpretations of pathogenicity
(Aug 6, 2022)
criteria provided, conflicting interpretations
89.
GRCh37:
Chr5:88145534
GRCh38:
Chr5:88849717
MEF2CIntellectual disability, autosomal dominant 20Uncertain significance
(Jun 25, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr5:88025063
GRCh38:
Chr5:88729246
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Mar 19, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr5:88100401
GRCh38:
Chr5:88804584
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Nov 1, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr5:88027711
GRCh38:
Chr5:88731894
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Jul 25, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr5:88018625
GRCh38:
Chr5:88722808
MEF2C-AS2, MEF2CE326*, E364*, E366*, E374*Intellectual disability, autosomal dominant 20Likely benign
(Sep 26, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr5:88100401-88100402
GRCh38:
Chr5:88804584-88804585
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Mar 9, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr5:88018547
GRCh38:
Chr5:88722730
MEF2C, MEF2C-AS2Intellectual disability, autosomal dominant 20Likely benign
(Sep 18, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr5:88119576
GRCh38:
Chr5:88823759
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Jan 19, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr5:88119539
GRCh38:
Chr5:88823722
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Oct 30, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr5:88024396
GRCh38:
Chr5:88728579
MEF2CIntellectual disability, autosomal dominant 20Likely benign
(Jul 19, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr5:88024380
GRCh38:
Chr5:88728563
MEF2CL194F, L218F, L288F, L296F, L334F, L336F, L344F, L354FIntellectual disability, autosomal dominant 20Likely benign
(Oct 18, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr5:88024304
GRCh38:
Chr5:88728487
MEF2CIntellectual disability, autosomal dominant 20Benign
(Sep 6, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination